Tempus AI (TEM) lies at the core of the healthcare revolution. It uses AI to turn medical data into practical insights to ...
We recently published a list of 10 Stocks Kick Off Trading Week With Losses. In this article, we are going to take a look at ...
Tempus announced its acquisition of Ambry Genetics at closing in November and the deal closed earlier this month.
Institutional investors bet big on Tempus AI (TEM), with massive Q4 stake increases from JPMorgan, UBS, and ARK Invest ...
Shares of Tempus AI, Inc. (NASDAQ:TEM – Get Free Report) have received an average rating of “Moderate Buy” from the twelve ...
6don MSN
Refusing to slow down since the start of the new year, shares of Tempus AI (NASDAQ: TEM) have skyrocketed nearly 99% since ...
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free ...
TEM basically mixes genomic and clinical data with AI. This is at the core of their new offerings for precision diagnostics ...
Tempus AI (TEM) stock surged 13.4% on Thursday, hitting a new 52-week high of $86. The upside came after the health ...
Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, will present at the TD Cowen 45th Annual Health Care Conference on March ...
Tempus AI shares soared to an all-time high Thursday as the tech firm announced a collaboration with the nonprofit Institute ...
Last year, more than $7.5 billion globally went to companies applying advances in artificial intelligence to health-related ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results